Transgene Biotek informs about standalone financial results

01 Jul 2014 Evaluate

Transgene Biotek has informed about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2014.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.15 0.13 (4.30%)
31-Dec-2025 14:29 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7041.85
Max Healthcare Inst 1046.85
Narayana Hrudayalay 1894.80
Aster DM Healthcare 613.90
Global Health 1183.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×